Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Significant Drop in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant drop in short interest in the month of August. As of August 14th, there was short interest totaling 3,083 shares, a drop of 70.3% from the July 30th total of 10,365 shares. Based on an average trading volume of 41,171 shares, the days-to-cover ratio is presently 0.1 days.

Alpha Tau Medical Stock Down 5.2%

Shares of DRTSW stock traded down $0.21 during trading on Friday, hitting $3.79. The company had a trading volume of 77,197 shares, compared to its average volume of 62,468. The stock’s 50-day moving average is $3.27 and its two-hundred day moving average is $2.06. Alpha Tau Medical has a 52 week low of $0.20 and a 52 week high of $4.28.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.